REGEND001
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for REGEND001, covering 2024-07-08 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]